IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login
Users Online :7037
Small font sizeDefault font sizeIncrease font size
Search Articles
   Simple Search
   Advanced Search
Goto Issues
   Current Issue
   Back Issues

Click here to submit original research article on COVID 19

5th IUPHAR WCP Natural products 2019

Indian Pharmacological Society - Executive Committee

Announcement Form

Apply as Referee Form

Adverse Reaction Reporting Form

Transfusion Reaction Reporting Form

 Table of Contents


Indian Journal of Pharmacology The Indian Journal of Pharmacology (ISSN 0253-7613) is an official publication of the Indian Pharmacological Society. The first issue of the journal came out in 1969 and in 1997 it was published Bimonthly.
IJP publishes original research articles, reviews, research letters and correspondences.

More about the journal

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data

The journal is indexed with, or included in, the following: EMBASE/ Excerpta Medica, Indian Science Abstracts, IndMed, MedInd, MEDLINE/Index Medicus, PubMed Central, Scimago Journal Ranking, SCOPUS, Science Citation Index Expanded, Web of Science

Impact Factor as reported in the 2021 Journal Citation Reports (Clarivate Analytics, 2022): 2.833

The 5 year Impact Factor of IJP is 2.237

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal



Current Issue:  November-December  2022 | Vol  54 | Issue  6  RSS Feed for Current Issue

Translational research: Bridging the gap between preclinical and clinical research
Vidya Mahalmani, Shweta Sinha, Ajay Prakash, Bikash Medhi
Drug discovery and development are lengthy and expensive process that takes nearly 10–15 years with an average amount of more than $1–2 billion for the approval of every novel drug for c...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Research Article
Lasmiditan abortive therapy for episodic migraine in Phase II/III randomized clinical trials: A meta-analysis
Marya Ahsan, Ayaz Khurram Mallick
OBJECTIVE: Although migraine is common, there are very few treatment options. Recently, lasmiditan, a specific 5-HT1F agonist, has gained approval as abortive therapy for migraine....
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Research Article
Use of drugs not listed in the National List of Essential Medicines: Findings from a prescription analysis by the Indian Council of Medical Research-Rational Use of Medicines Centres Network in tertiary care hospitals across India
Ratinder Jhaj, Aditya Banerjee, Nilima Arun Kshirsagar, Balakrishnan Sadasivam, Sujith J Chandy, Heber Rew Bright, Preetha Kaur Chugh, CD Tripathi, Dinesh Kumar Badyal, Madhulika Peter Samuel, Bikash Medhi, Ajay Prakash, Rupa Joshi, Sandhya Kamat, Raakhi Tripathi, Urwashi Indrakumar Parmar, Harihar Dikshit, Hitesh Mishra, Sukalyan Saha Roy, Niyati Trivedi, Janki Chauhan, Suparna Chatterjee, Manjari Bhattacharya, Chetna K Desai, Shamil Sheth, Pooja Gupta, Atanu Roy, Ramasamy Raveendran, Jayanthi Mathaiyan, G Jeevitha, Sandeep Kaushal, Kanchan Gupta, Samriti Jain, Rajni Kaul
BACKGROUND: The concept of listing essential medicines can lead to improved supply and access, more rational prescribing, and lower costs of drugs. However, these benefits hinge on the prescr...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 Read more....
TOC Table of Contents   Site Statistics Access Statistics

The journal is now included in Science Citation Index (SCI) and Journal Citation Report (JCR).
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow